Vimab Group AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 66.43 million compared to SEK 50.18 million a year ago. Revenue was SEK 66.66 million compared to SEK 51.59 million a year ago. Net loss was SEK 15.65 million compared to SEK 9.55 million a year ago. Basic loss per share from continuing operations was SEK 0.8 compared to SEK 3.5 a year ago.
For the full year, sales was SEK 227.29 million compared to SEK 205.68 million a year ago. Revenue was SEK 229.25 million compared to SEK 209.04 million a year ago. Net loss was SEK 34.22 million compared to SEK 24.09 million a year ago. Basic loss per share from continuing operations was SEK 3.4 compared to SEK 8.9 a year ago.